Skip to content
Discover J&J
Medicines & therapies
Medical devices & technology
Discover J&J
Medicines & therapies
Medical devices & technology
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Policy Briefs
2024 U.S. Drug Pricing Transparency Report: Patient access and affordability
The 340B Program: Missing the mark for patients
Perspectives
& insights
About us
Menu
Center for
U.S. Healthcare
Policy Research
Research
areas
Research areas
Value
Access
Innovation
All content
Transparency Report
& Policy Briefs
2024 U.S. Drug Pricing Transparency Report: Patient access and affordability
The 340B Program: Missing the mark for patients
Perspectives
& insights
About us
Show Search
Search Query
Submit Search
Clear
Dictate search request
Search Results
No Results
Recently Viewed
Listening...
Sorry, I don't understand. Please try again
Home
/
Transparency
/
The 340B Program: Missing the mark for patients
Transparency
The 340B Program: Missing the mark for patients
At a glance
August 5, 2025
1 min read
Share
Share Article
Share to
Twitter
LinkedIn
Email
Copy link
Link copied
Download the PDF
here
.
Transparency
340B
